Woodline Partners »

Supernus Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $44M 1.3M 34.11
2022-12-31 $3.8M 106k 35.67
2022-09-30 $27M 794k 33.85
2022-06-30 $16M 569k 28.92
2022-03-31 $16M 485k 32.32
2021-09-30 $1.4M 54k 26.67